James P. Moran - 01 Apr 2026 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Reporting relationship: Director
Issuer ticker: IGC
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Apr 2026, 16:02:01 UTC
Prior SEC filing: 21 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ James Moran

Key filing fact

James P. Moran filed Form 4 for IGC Pharma, Inc. (IGC) on 06 Apr 2026.

Key facts

This page summarizes James P. Moran's Form 4 filing for IGC Pharma, Inc. (IGC).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 06 Apr 2026, 16:02.

Change

Previous filing in this sequence was filed on 21 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001907094 Primary reporting owner

Moran James P

Relationship: Director
Address: 10224 FALLS ROAD, POTOMAC
Signature: /s/ James Moran
Signature date: 06 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IGC transaction

Common Stock

Options Exercise

Transaction value
Shares: +80,000
Change %: +7.2%
Price: $0.000000^*
Shares after: 1,185,735
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F1

IGC transaction

Common Stock

Options Exercise

Transaction value
Shares: +50,000
Change %: +4.2%
Price: $0.000000^*
Shares after: 1,235,735
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IGC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -80,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 80,000
Exercise price
Footnotes: F1, F3

IGC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -50,000
Change %: -50%
Price: $0.000000^*
Shares after: 50,000
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

Footnote F2

On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025.

Footnote F3

Each restricted stock unit represents a right to receive one share of IGC common stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .